ORTHO
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 7160

Bone Cells QID: 7160 (SAE10BS.72)
In scope icon L 4 E
QID 7160 (Type "7160" in App Search)
Intermittent daily administration of recombinant parathyroid hormone (rhPTH) is an FDA-approved treatment for osteoporosis. Intermittent rhPTH treatment targets which of the following cells in osteoporotic patients?
Type in at least one full word to see suggestions list
Add Colleague
Lab Values
Calculator
Content analytics